 |
Dextroamphetamine (Latest Articles)
Latest indexed articles for 'Dextroamphetamine'
Articles 1 to 10 of 200:
30 Aug 2009 
OBJECTIVE: To evaluate the pharmacokinetics of lisdexamfetamine dimesylate (LDX), a long-acting prodrug stimulant, and mixed amphetamine salts extended-release (MAS XR), alone or with omeprazole, a proton pump inhibitor (PPI). METHODS: This ...
rec_pub_19820270-effects-omeprazole-pharmacokinetic-profiles-lisdexamfetamine.htm
Sudden death and use of stimulant medications in youths.
13 Jun 2009 OBJECTIVE: The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. METHOD: A matched case-control design was performed. ...
rec_pub_19528194-sudden-death-use-stimulant-medications-youths.htm
5 Jun 2009 AIMS: This study investigated the role of the cannabinoid CB1 receptor agonist, WIN 55,212-2, on motor activity. Subsequently, the effects of a low, stimulatory dose of WIN 55,212-2 and cocaine, as a positive control, were evaluated using a ...
rec_pub_19508876-behavioural-dopaminergic-alterations-induced-low-dose-win-55-212-2.htm
30 May 2009 
The purpose of the experiments was to examine the anxiety-related effects of d-amphetamine and nicotine, and the possible involvement of the endocannabinoid system. D-amphetamine (2 mg/kg, ip) was administered acutely or daily for 8 days. On the 9th ...
rec_pub_19617654-effects-cannabinoid-receptor-ligands-anxiety-related-effects-d.htm
The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD.
29 Apr 2009 Pharmacotherapy plays a primary role in the management of attention-deficit/hyperactivity disorder (ADHD), despite the availability of effective behavioral interventions. Psychostimulants are the most commonly prescribed form of pharmacotherapy for ...
rec_pub_19601689-the-role-pharmacotherapy-managed-care-pharmacy-interventions.htm
Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
29 Apr 2009 Although symptoms of attention-deficit/ hyperactivity disorder (ADHD) are certainly most visible in children, the syndrome persists into adolescence in 40% to 70% of cases and into adulthood in 50% or more of cases. Accurate recognition of the ...
rec_pub_19601688-clinical-considerations-diagnosis-treatment-adhd-managed-care-setting.htm
29 Apr 2009 There is a need for novel anxiolytics, which are effective, but do not cause sedation, tolerance, and rebound anxiety on discontinuation. To investigate a procedure that can be used to assess these characteristics preclinically, rats were initially ...
rec_pub_19455771-a-novel-operant-conflict-procedure-using-incrementing-shock.htm
Treatment for amphetamine withdrawal.
13 Apr 2009 BACKGROUND: Few studies examined treatments for amphetamine withdrawal, although it is a common problem among amphetamine users. Its symptoms, in particular intense craving, may be a critical factor leading to relapse to amphetamine use. In clinical ...
rec_pub_19370579-treatment-amphetamine-withdrawal.htm
6 Apr 2009 Some of the behavioral effects of d-amphetamine (d-AMPH) are mediated by an increase in dopamine neurotransmission in the nucleus accumbens. However, there is evidence that gamma-amino-butyric-acid-B (GABA-B) receptors are involved in some ...
rec_pub_19361543-the-gaba-b-antagonist-2-hydroxysaclofen-reverses-effects-baclofen.htm
31 Mar 2009 In the study of functional connectivity, fMRI data can be represented mathematically as a network of nodes and links, where image voxels represent the nodes and the connections between them reflect a degree of correlation or similarity in their ...
rec_pub_19345737-community-structure-networks-functional-connectivity-resolving.htm
Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]